Yabao Pharmaceutical of China was granted tentative approval by the FDA for sorafenib tosylate, a biosimilar to Bayer's cancer drug Nexavar, or sorafenib.
Tentative approval granted by FDA to Yabao's Nexavar biosimilar
Sign up for BIO SmartBrief
Biotechnology industry news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.